A Resource for Healthcare and Social Services Professionals
Estimated time to complete: 30 minutes
As shortened version of Grayken TTA's Addiction 101 training, this 30-minute training provides an overview of the disease model of addiction, the overdose epidemic, stigma, and evidence-based treatments for persons with substance use disorder. CEs: CME (0.50); Nursing (0.50); LADC/CADC (0.50); RC (0.50)
Substance Use Disorders 101: The Overview is a 30-minute version of Grayken Center for Addiction TTA’s Addiction 101 training. This training provides an overview of the disease model of addiction, the overdose epidemic, stigma, and evidence-based treatments for persons with substance use disorder.
This training satisfies 0.50 hours of the required 8 hours of training for DEA-registered practitioners. The Medication Access and Training Expansion (MATE) Act was included in the Consolidated Appropriations Act, 2023. The MATE Act requires increased training for Drug Enforcement Administration (DEA)-registered physicians and practitioners—specifically, a one-time eight-hour training requirement on treating and managing patients with opioid or other substance use disorders.
This training aims to reach a broad audience of interdisciplinary healthcare teams as well as other professionals and members of the community seeking to learn about substance use disorders.
Other Faculty
Daniel P. Alford, MD, MPH, FACP, FASAM, CME Course Director, has no relevant financial relationships to disclose.
Colleen LaBelle, MSN, RN-BC, CARN Nursing Course Director, has no relevant financial relationships to disclose.
Members of the planning committee have no relevant financial relationships to disclose:
Ilana Hardesty, MA, Planning Committee
Victoria Rust, BS, Planning Committee
Kristin Wason, MSN, NP-C, CARN (she/her)
Kristin is a clinical nurse educator for Boston Medical Center's Grayken Center for Addiction Training and Technical Assistance, an assistant professor of medicine at Boston University Chobanian & Avedisian School of Medicine, and a nurse practitioner at Boston Medical Center. Kristin contributes to peer-reviewed publications, evidence-based clinical guidelines, development and delivery of continuing education programs, and other resources for clinicians supporting patients with substance use disorders. Kristin is the Director of the Grayken Addiction Nurse Fellowship program, the first addiction nurse fellowship of its kind in the United States. She also sits on the BMC Substance Use Disorder Nursing Council. Kristin is an expert faculty member for the Provider Clinical Support System Exchange (PCSS-X) and co-chair of the Association for Multidisciplinary Education and Research in Substance Use and Addiction 2022 conference. Kristin's clinical interests include women's health, low-barrier treatment, and care of persons involved within the criminal-legal system. She is board-certified in addictions through the Addiction Nursing Certification Board. She earned her Master of Science in Nursing (MSN) from Salem State University and completed her undergraduate studies at the University of New Hampshire.
Kristin has no relevant financial relationships to disclose.
Following this training, participants will have the knowledge necessary to:
Boston Medical Center Grayken Center for Addiction Training and Technical Assistance, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)
Funding for out of state attendees is provided by the Opioid Response Network (ORN).
Funding for this initiative was made possible (in part) by grant no. 1H79TI083343 & 1H79TI085588-02 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Accreditation Statement for CME and Nursing
In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Continuing Medical Education (CME): Boston University Chobanian & Avedisian School of Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Contact Hours: 0.50 number of contact hours of which 0.00 are eligible for pharmacology credit.
Accreditation Statement for LADC/CADC and Recovery Coach
Boston Medical Center Grayken Center for Addiction Training and Technical Assistance has approval from the Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS) to award LADC/CADC and Recovery Coach credits equal to 0.50 credits for enduring training completion.
Program Expiration
This program expires on 07/14/2025.
Requirements for Credit
Requirements for Credit: To earn credit, one must complete the pre-test, video, and pass the post-test evaluation with a minimum score of 70%. The evaluation closes two weeks after watching the video.
Speaker/Planner Disclosures & Disclaimer
Boston University Chobanian & Avedisian School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University Chobanian & Avedisian School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships that faculty, planners, authors, and anyone who may be in control of content have with ineligible companies have been mitigated.
Faculty members do not plan on discussing off-label/investigational uses of a commercial product.
THIS CONTINUING EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.